Journal: Frontiers in Immunology
Article Title: SARS-CoV-2 Spike protein alters microglial purinergic signaling
doi: 10.3389/fimmu.2023.1158460
Figure Lengend Snippet: SARS−CoV−2 spike protein increases purinergic signaling components transcript levels in mice hippocampus. The levels of transcripts for (A) P2X7, (B) P2X4, (C) P2Y 1 , (D) P2Y 2 , (E) P2Y 4 , (F) P2Y 6 , (G) P2Y 12 , (H) E-NTPDase1, (I) E-NTPDase2, (J) E-NTPDase3, and (K) CD73 in hippocampus of mice post-spike ICV injection were analyzed by RT-qPCR. Data are expressed as mean ± SEM. Statistically significant differences between the control (Ctrl) and treated group are represented by asterisks (*, p < 0.05). Outliers were identified and excluded using Prism 8.0.1 software (GraphPad Software, La Jolla, CA, USA). Student’s t-test (Control group n = 3; Spike group n = 5–7).
Article Snippet: Samples were then incubated overnight with the following primary antibodies diluted in 0.1% BSA in PBS: rabbit anti-P2X7 #APR-008 (1:100), rabbit anti-P2Y 1 #APR-009 (1:100), rabbit anti-P2Y 4 #APR-006 (1:300), rabbit anti-P2Y 6 #APR-011 (1:500), rabbit anti-P2Y 12 #APR-012 (1:50) (Alomone Labs, Jerusalem, Israel), goat anti-CD39 #AF4398 (1:200) (R&D Systems, Minneapolis, MN), rabbit ENTPD2/CD39L1 # BS-11515R (1:100) (Thermo Fisher Scientific, NJ, USA).
Techniques: Injection, Quantitative RT-PCR, Control, Software